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Right Ventricular Metastasis from Unclassified  
Renal Cell Carcinoma 
 
Abstract 
Background: Cardiac metastasis of unclassified renal cell carcinoma (RCC) subtype is 
very rare, and even more so is an isolated right ventricular (RV) metastasis without vena 
cava extension or right atrial involvement. To the best of our knowledge, this is the first 
report of a cardiac metastasis of an unclassified RCC (an aggressive RCC) without vena 
cava extension. 
Case Presentation: A 61-year-old African American male with past medical history of 
hypertension and schizophrenia presented to the emergency room following 2 episodes of 
syncope and 3-month history of progressive neck mass. CT scan of neck, abdomen and 
pelvis showed bulky left cervical, supraclavicular and axillary lymph node, mass in 
anterior aspect of heart, and multiple solid left renal masses and probable right renal mass. 
Echocardiogram revealed a large RV mass with deformation of the RV free wall 
suggesting malignant growth. Core biopsy of the right superficial gluteal mass revealed a 
metastatic poorly differentiated carcinoma of likely renal origin, with a possibility of an 
unclassified RCC. Due to the extent and burden of metastasis, patient and family members 
agreed to conservative management and evaluation for hospice care. 
Conclusion: Cardiac metastasis of unclassified RCC is rare, and even more so is an 
isolated RV metastasis without vena cava extension or right atrial involvement, and the 
present case, to the best of knowledge is the first of such rare presentation. 
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Metastatic cardiac tumors are more prevalent than primary cardiac tumors (1), and 
they arise most often from malignant melanoma, lung cancers, breast cancers, esophageal 
cancers, leukemia and lymphomas (2). Renal cell carcinoma (RCC) metastasis to the heart 
is rare, even more so is the metastasis of an undifferentiated RCC to the right ventricle 
(RV) without an inferior vena cava (IVC) or right atrial (RA) extension. The most 
common mechanism of cardiac metastasis in RCC is through direct tumor thrombus 
extension through the renal veins and IVC to the right side of the heart (3), and 
dissemination through hematogenous or lymphatic spread is reported as the second most 
common mechanism of metastasis (4). The clear cell RCC is the most commonly reported 
histopathology to the heart, and to the best of our knowledge, this is the first reported case 
of an unclassified RCC metastasis to the heart. We report a metastatic unclassified and 
poor differentiated RCC to the RV without a contiguous IVC or RA involvement.  
 
Case Presentation 
A 61-year-old African American male with past medical history of hypertension and 
schizophrenia presented to the emergency room following 2 episodes of syncope.  
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He reported 3 month history of progressive neck mass. 
Physical examination revealed a temperature of 37.7 degrees, 
blood pressure of 130/87 mmHg, pulse of 92 bpm, and 
respiratory rate of 17 bpm. There was extremely large left 
sided neck mass extending into the left axilla and multiple 
palpable left and right cervical lymph nodes. The lungs were 
clear to auscultation, and there was a 2/6 systolic ejection 
murmur heard best at the bases. The abdomen was soft and 
nontender, without palpable organomegaly. There was a 5x2 
cm right gluteal non-tender, non-mobile mass with central 
ulceration and also a 2x2 cm spherical mass at the left upper 
back with small central ulceration. There was 2+ pitting 
edema of the lower extremities bilaterally. There was 
differential swelling of left upper extremity. Electrocardiogram 
showed normal sinus rhythm, left axis deviation, low voltage 
and mild t wave inversion in V2–V4 (figure 1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Electrocardiogram showing normal sinus 
rhythm, left axis deviation, low voltage and mild t-wave 
inversion in V2 – V4 
 
Initial CT scan of the abdomen and pelvis showed diffuse 
metastatic disease of the visualized lower chest, abdomen 
and pelvis including superficial soft tissues, left kidney, and 
probable right kidney. There was diffuse confluent 
adenopathy and massive right inguinal lymphadenopathy, 
along with pronounced diffuse anasarca. There are multiple 
renal masses. There are solid masses arising off of the lateral 
aspect of the left kidney involving the upper, middle and 
lower lobe (figure 2). The left kidney mass was described as 
an exophytic lesion. There was a mass along the anterior 
aspect of the heart that measures approximately 5 cm but 
incompletely visualized. CT head was negative.  
Transthoracic echocardiogram revealed a large mass 
measuring 4.8 cm x 3.0 cm extending from the apex to the 
mid RV cavity, and extending into the RV outflow tract 
stopping just short of the pulmonic valve (figure 3). There 
was deformation of the RV free wall suggesting invasion of 
the myocardial wall and a malignant growth. There was mild 
RV enlargement, with normal function of the segments not 
involved in mass. There RA was mildly dilated with no mass 
seen, and there was no evidence of thrombus in the IVC. 
There was a small pericardial effusion without 
echocardiographic evidence of tamponade. A dedicated CT 
of the thorax revealed a mildly enlarged heart, and a filling 
defect in the RV measuring 6 cm extending to the apex and 
suspicious for malignancy (figure 4).  
 
 
 
 
 
 
 
 
Figure 2: Panel A: Cross-section of CT abdomen and 
pelvis showing left renal mass. Panel B: Coronal section 
of CT abdomen and pelvis showing left renal mass 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Apical 4-chamber view demonstrating a large 
mass measuring 4.8 cm x 3.0 cm extending from the apex 
to the mid right ventricular cavity. LA Left atrium; LV 
Left ventricle; RA Right atrium; RV Right ventricle. 
 
A core biopsy of the right superficial gluteal mass 
revealed a tumor arranged in solid nests having abundant 
eosinophilic cytoplasm, central nucleus and conspicuous 
nucleoli, with areas of coagulative tumor necrosis, and 
individual tumor cell exhibiting high-grade atypia with 
pleomorphism (figure 5).  
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Figure 4: Cross sectional view of CT thorax showing a 
large right ventricular mass. Arrow: Deformation of 
right ventricular free wall suggesting infiltration of right 
ventricular mass into the right ventricular wall 
myocardium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Pathology of right gluteal mass biopsy 
suggesting metastatic carcinoma of renal origin, possibly 
of an unclassified renal cell carcinoma. Panel A & B 
showing magnification x 4 and magnification x 40 
respectively. Tumor cells are arranged in solid nests 
having abundant eosinophilic cytoplasm, central nucleus 
and conspicuous nucleoli. Panel C: Pancytokeratin 
expression in tumor cells. Panel D: PAX8 expression in 
tumor cells with strong nuclear staining. 
 
On immunohistochemistry, the tumor cells expressed 
pacytokeratin, PAX 8, vimentin and CD 10 (weakly). The 
tumor cells are negative for S 100, Melan-A and RCC. 
Immunostains for CD 117 and CK 7 were performed, 
however were uninterpretable due to tissue depletion. 
Morphology and immunohistochemical profile favor a 
metastatic poorly differentiated carcinoma of likely renal 
origin, with a possibility of an unclassified RCC. Oncology 
was consulted and they suggested a diffuse metastatic 
malignancy of primary renal origin with poor prognosis. 
Oncology advised that the patient should follow up in 
outpatient cancer clinic. Due to extent and burden of 
metastasis, patient and family members agreed to 
conservative management and patient was placed in hospice 
and comfort care with no further aggressive management. He 
was discharged from the hospital to hospice and to follow-up 
with the cancer clinic, although there were no records that he 
kept the appointments and he was lost to follow-up. 
 
 
Discussion 
RCC metastasis to the heart is rare. Most secondary 
tumor metastasis to the heart often arises from malignant 
melanoma, lung cancers, breast cancers, esophageal cancers, 
leukemia and lymphomas (2). RCC presents as a localized or 
locally advanced tumor in approximately 45% and 25% of 
patients, respectively, and 30% of patients may have 
metastasis at the time of diagnosis (5).  The most common 
site for RCC metastasis is lungs, bone, soft tissues, liver and 
central nervous system (5). With cardiac metastasis, a direct 
tumor extension through the renal veins and IVC to the right 
side of the heart is the most common mechanism of spread, 
followed by dissemination through hematogenous or 
lymphatic spread (3, 4, 6). The histopathology of most 
reported cardiac metastatic RCC is the clear cell subtype. 
Unclassified RCC subtype is a very rare variant and accounts 
for approximately 3-5% of RCC cases (7).  
They possess adverse histopathological features and 
aggressive biological potential; are usually advanced at the 
time of diagnosis, and associated with poor clinical outcome 
and higher mortality compared to other RCC subtypes (8, 9). 
Our patient presented with syncope and was found to have 
diffuse metastatic disease of the lower chest, abdomen and 
pelvis including superficial soft tissues, diffuse confluent 
lymphadenopathies and an RV mass, with a core biopsy of 
gluteal mass showing metastatic poorly differentiated 
carcinoma of likely renal origin, with a possibility of an 
unclassified RCC. To the best of our knowledge, this is the 
first reported case of a poorly differentiated unclassified 
RCC metastasis to the RV, and without contiguous IVC or 
RA involvement. There was also invasion of the RV 
myocardial free wall. The episode of syncope may due to 
intermittent obstruction of flow through the RV outflow tract 
with subsequent reduction in LV preload and forward flow, 
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although at the time of echocardiography, there was no flow 
limitation or RV outflow obstruction. The possibility of 
tachydysrhythmias and conduction defects has a cause of 
syncope in patients with cardiac metastatic RCC has also 
been reported likely due to re-entry around the border with 
the myocardium, accessory bundles resulting in ventricular 
pre-excitation and valvular interference of the tumor mass (4, 
5).  Metastatic RCC, unlike other neoplasm are highly 
resistant to chemotherapeutic, hormonal and radiation 
therapy, however recent targeted therapeutic agents such as 
(sunitinib, sorafenib, pazopanib, axitinib, bevacizumab, 
temsirolimus and everolimus) are now standard therapy and 
these tumor cells have shown sensitivity to immunotherapy 
such as interleukin 2 and interferon (10, 11). Surgical 
resection may be considered for isolated intracavitary cardiac 
metastasis and appears to have a good prognosis, however 
most presentations are late with diffuse metastasis and treatment 
is palliative (10, 11). A combination of both surgical resection in 
isolated cardiac metastatic cases or metastasectomy if 
feasible and novel chemotherapy agents may produce a 
desired result of both palliation and cure (10, 12).  
In conclusion, RCC metastasis to the heart is rare, and it 
commonly arises as a direct tumor thrombus extension into 
the RA through the IVC especially in clear cell RCC or from 
either hematogenous or lymphatic spread. Cardiac metastasis 
of unclassified RCC is rare, and even more so is an isolated 
RV metastasis without IVC or RA involvement, and the 
present case is one of such rare presentation.  
 
Conflict of Interest: None declared. 
 
References 
1. Lam KY, Dickens P, Chan AC. Tumors of the heart. A 
20-year experience with a review of 12,485 consecutive 
autopsies. Arch Pathol Lab Med 1993; 117: 1027-1031. 
2. Klatt EC, Heitz DR. Cardiac metastases. Cancer 1990; 65: 
1456-9. 
3. Hoffmann U, Globits S, Frank H. Cardiac and paracardiac 
masses. Current opinion on diagnostic evaluation by 
magnetic resonance imaging. Eur Heart J 1998; 19: 553-
63. 
4. Kwon MJ, Kim DS, Kim AR, et al. A case of multiple 
metastatic renal cell carcinoma in an adult patient 
presenting with ventricular tachycardia. Korean Circ J 
2005; 35: 341-4. 
5. Alghamdi A, Tam J. Cardiac metastasis from a renal cell 
carcinoma. Can J Cardiol 2006; 22: 1231-2. 
6. Brufau BP, Cerqueda CS, Villalba LB, et al. Metastatic 
renal cell carcinoma: Radiologic findings and assessment 
of response to targeted antiangiogenic therapy by using 
multidetector CT. Radiographics 2013; 33: 1691-716. 
7. Kovacs G, Akhtar M, Beckwith BJ, et al. The heidelberg 
classification of renal cell tumours.  J Pathol 1997; 183: 
131-3. 
8. Karakiewicz PI, Hutterer GC, Trinh Q, et al. Unclassified 
renal cell carcinoma: An analysis of 85 cases. BJU Int 
2007; 100: 802-8. 
9. Zisman A, Chao DH, Pantuck AJ, et al. Unclassified renal 
cell carcinoma: Clinical features and prognostic impact 
of a new histological subtype. J Urol 2002; 168: 950-5. 
10. Bazine A, Fetohi M, Tanz R, et al. Cardiac metastases of 
renal cell carcinoma revealed by syncope: Diagnosis and 
treatment. Case Rep Oncol 2014; 7: 560-4. 
11. Zhang B, Malouf J, Young P, Kohli M, Dronca R. 
Cardiac metastasis in renal cell carcinoma without vena 
cava or atrial involvement: An unusual presentation of 
metastatic disease. Rare Tumors 2013; 5: 103-5. 
12. Aburto J, Bruckner BA, Blackmon SH, Beyer EA, 
Reardon MJ. Renal cell carcinoma, metastatic to the left 
ventricle. Tex Heart Inst J 2009; 36: 48-9. 
 
